Iniciar sesión Regístrese gratis

Intercept Pharmaceuticals Inc Ingresos Q/Q

¿Qué es el Ingresos Q/Q de Intercept Pharmaceuticals Inc?

El Ingresos Q/Q de Intercept Pharmaceuticals Inc es 14.44%

¿Cuál es la definición de Ingresos Q/Q?

El crecimiento de los ingresos trimestrales, año tras año, es el aumento de los ingresos de una empresa en comparación con el compiortamiento en el trimestre correspondiente de un año anterior expresado como un porcentaje.

Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.

Ingresos Q/Q de compañías en Sector Health Care en NASDAQ en comparadas con Intercept Pharmaceuticals Inc

¿Qué hace Intercept Pharmaceuticals Inc?

we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.

Empresas con ingresos q/q similar a Intercept Pharmaceuticals Inc